Neural Implants Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Neural Implants Market Size By 2025?
The market for neural implants has seen significant expansion in the past few years. The market size is predicted to increase from $5.39 billion in 2024 to $5.91 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.8%. The historic period's growth can be linked to the expansion of top-notch healthcare facilities, increase in aging populace, rise in preference for low invasive methods, boost in requirement for individualized treatment solutions, and the provision of enhanced healthcare infrastructure.

How Big Is the Neural Implants Market Size Expected to Grow by 2029?
Forecasts predict a robust expansion of the neural implants market in the upcoming years, with an estimated value of $8.56 billion in 2029 and a compound annual growth rate (CAGR) of 9.7%. The expected growth in the forecast period can be ascribed to several factors including an increase in neurological illnesses, heightened patient awareness concerning new neurological disorder treatments, increased availability of useful devices, a preference trend towards MR-conditional brain implants, and the enhanced use of high-frequency neuromodulation therapy. Other notable growth trends projected for the forecast period encompass advancements in product innovation, technology, neuroprosthetics, and the incorporation of deep learning algorithms into neural implants.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report

Which Key Market Drivers Powering Neural Implants Market Expansion and Growth?
The growth of the neural implants market is anticipated to be driven by the increasing incidence of neurological disorders. Neurological disorders are conditions involving the nervous system, encompassing irregularities in the brain, spinal cord, or peripheral nerves, which can be anatomical, biochemical, or electrical. The rise in these disorders is facilitated by various aspects such as aging populations, genetic factors, and modifications in diagnostic standards. Neural implants serve to manage a range of neurological conditions by directly interfacing with the nervous system, consequently restoring or enhancing neural functions. These devices offer a customized approach that could heighten therapy outcomes and minimize negative effects, specifically in diseases like Parkinson's disease, epilepsy, and spinal cord injuries. For example, data from the Alzheimer's Association, a US-based voluntary health organization specializing in Alzheimer's disease care, revealed in March 2022 that nearly 7 million Americans above the age of 65 were afflicted with Alzheimer's dementia. This figure is projected to rise to 13.8 million by 2060. Furthermore, the healthcare and long-term care expenses for individuals with dementia are expected to hit $360 billion in 2024 and approach $1 trillion by 2050. Consequently, the escalating prevalence of neurological disorders is steering the expansion of the neural implants market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15618&type=smp

What Trends Will Shape the Neural Implants Market Through 2029 and Beyond?
In the neural implant market, prominent businesses are zeroed in on the creation of pioneering products, like deep brain stimulation (DBS) devices, in order to treat motor disorders like Parkinson's disease and essential tremors, consequently securing a competitive edge in the market. DBS devices are medical implants that treat neural disorders by transmitting electrical impulses to designated sections of the brain. As an example, in January 2024, Abbott Laboratories, a healthcare and medical devices enterprise based in the US, introduced Liberta RC, the globe's tiniest rechargeable deep brain stimulation (DBS) device with remote programming, designed to help individuals afflicted with motor disorders. The device necessitates the minimum amounts of recharges among any FDA-approved DBS device, demanding merely 10 recharge sessions annually for the majority of users. This product is integrated with the exclusive NeuroSphere virtual clinic of Abbott, enabling clients to communicate with clinicians, verify correct settings and functionality, and obtain updated treatment settings virtually. The system utilizes a wireless charger that can be positioned above the device, so users can stay active while wearing it. The device consists of customer-friendly alerts and personalized settings providing for tailored charging experiences.

What Are the Emerging Segments in the Neural Implants Market?
The neural implants market covered in this report is segmented -

1) By Product: F And B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)
2) By Application: Chronic Pain, Parkinson's Disease (PD), Epilepsy, Other Applications
3) By End-User: Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers

Subsegments:
1) By F And B Spinal Cord Stimulation (Scs): Traditional Spinal Cord Stimulation, High-Frequency Spinal Cord Stimulation, Burst Spinal Cord Stimulation
2) By Deep Brain Stimulation (Dbs): Subthalamic Nucleus (Stn) Dbs, Globus Pallidus Internus (Gpi) Dbs, Ventral Intermediate Nucleus (Vim) Dbs
3) By Vagus Nerve Stimulation (Vns): Implantable Vagus Nerve Stimulators, Non-Invasive Vagus Nerve Stimulators

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15618&type=smp

Who Are the Global Leaders in the Neural Implants Market?
Major companies operating in the neural implants market are Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Smith & Nephew plc, Integra LifeSciences, Cochlear Ltd., LivaNova PLC, Renishaw plc, MicroPort Scientific Corporation, Nevro Corp., Inspire Medical Systems Inc., Cyberonics Inc., Axonics Modulation Technologies Inc., Saluda Medical, NeuroPace Inc., Fisher Wallace, BioControl Medical, Cerbomed GmbH, Nuvectra Corporation

Which are the Top Profitable Regional Markets for the Neural Implants Industry?
North America was the largest region in the neural implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15618

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.